PET Imaging of Upregulated VLA-4 in a Novel Mouse Model of BRAFV600E Melanoma

被引：0
|
作者：
Nyiranshuti, Lea
Bellavia, Michael C.
Latoche, Joseph D.
Fecek, Ronald
Taylor, Jennifer
Nigam, Shubhanchi
Patel, Ravi
Storkus, Walter
Anderson, Carolyn
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Lake Erie Coll Osteopath Med Seton Hill, Greensburg, PA USA
[4] Univ Missouri, Columbia, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
96
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PET Imaging of VLA-4 in a New BRAFV600E Mouse Model of Melanoma
    Michael C. Bellavia
    Lea Nyiranshuti
    Joseph D. Latoche
    Khanh-Van Ho
    Ronald J. Fecek
    Jennifer L. Taylor
    Kathryn E. Day
    Shubhanchi Nigam
    Michael Pun
    Fabio Gallazzi
    Robert S. Edinger
    Walter J. Storkus
    Ravi B. Patel
    Carolyn J. Anderson
    Molecular Imaging and Biology, 2022, 24 : 425 - 433
  • [2] PET Imaging of VLA-4 in a New BRAFV600E Mouse Model of Melanoma
    Bellavia, Michael C.
    Nyiranshuti, Lea
    Latoche, Joseph D.
    Ho, Khanh-Van
    Fecek, Ronald J.
    Taylor, Jennifer L.
    Day, Kathryn E.
    Nigam, Shubhanchi
    Pun, Michael
    Gallazzi, Fabio
    Edinger, Robert S.
    Storkus, Walter J.
    Patel, Ravi B.
    Anderson, Carolyn J.
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (03) : 425 - 433
  • [3] Targeting BRAFV600E in an Inducible Murine Model of Melanoma
    Hooijkaas, Anna I.
    Gadiot, Jules
    van der Valk, Martin
    Mooi, Wolter J.
    Blank, Christian U.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (03): : 785 - 794
  • [4] cAMP signaling in BRAFV600E melanoma
    Rodriguez, Carlos I.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    British Journal of Cancer, 2013, 108 : 924 - 931
  • [6] Modulation of MHC expression by BRAFV600E in melanoma
    Pollack, B. P.
    Sapkota, B.
    Hill, C. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S224 - S224
  • [7] Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
    Menzies, Alexander M.
    Lum, Trina
    Wilmott, James S.
    Hyman, Jessica
    Kefford, Richard F.
    Thompson, John F.
    O'Toole, Sandra
    Long, Georgina V.
    Scolyer, Richard A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 377 - 382
  • [8] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [9] Melanoma Drug Approved for Patients With BRAFV600E
    Smart, Michael
    ONCOLOGY NURSING FORUM, 2011, 38 (06) : 739 - 740
  • [10] PNA as novel targeted cancer therapy for BRAFV600E mutant melanoma
    Rothman, Jeffrey H.
    Surriga, Oliver
    Vasudeva, Shyamprasad D.
    Ambrosini, Grazia
    Ouerfelli, Ouathek
    Schwartz, Gary K.
    CANCER RESEARCH, 2014, 74 (19)
12345